STOCK TITAN

[Form 4] Blend Labs, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Form 4 Overview: Blend Labs, Inc. (BLND) filed a Form 4 disclosing that Brian Kneafsey, the company’s Head of Revenue, sold 20,000 shares of Class A common stock on 23 June 2025.

Transaction specifics: The disposition was coded “S” (open-market sale) and executed at a weighted-average price of $3.1657 per share, within a range of $3.12–$3.205. Following the sale, Kneafsey still beneficially owns 806,598 shares, indicating the transaction reduced his direct holdings by roughly 2.5%.

Rule 10b5-1 plan: The insider noted that the trade was carried out under a Rule 10b5-1 trading plan adopted on 14 March 2025. Pre-arranged plans can mitigate concerns about informational advantage because trades are scheduled in advance.

Ownership context: Kneafsey is classified as an Officer – Head of Revenue; no director or 10% ownership status was indicated. The filing is made by a single reporting person, and there are no derivative security transactions reported.

Investor takeaways: While any insider sale can draw attention, the size of this sale is modest relative to the insider’s remaining stake, and its execution under a 10b5-1 plan lessens potential negative signalling. No information about Blend Labs’ operational performance, earnings, or other corporate events is provided in this filing.

Panoramica del Modulo 4: Blend Labs, Inc. (BLND) ha presentato un Modulo 4 che rivela che Brian Kneafsey, Responsabile delle Entrate dell'azienda, ha venduto 20.000 azioni ordinarie di Classe A il 23 giugno 2025.

Dettagli della transazione: La cessione è stata classificata come “S” (vendita sul mercato aperto) ed è stata eseguita a un prezzo medio ponderato di 3,1657 $ per azione, in un intervallo compreso tra 3,12 e 3,205 $. Dopo la vendita, Kneafsey detiene ancora 806.598 azioni, il che indica che la transazione ha ridotto la sua partecipazione diretta di circa il 2,5%.

Piano Rule 10b5-1: L’insider ha specificato che la vendita è stata effettuata nell’ambito di un piano di trading Rule 10b5-1 adottato il 14 marzo 2025. I piani predefiniti possono ridurre le preoccupazioni relative a vantaggi informativi poiché le operazioni sono programmate in anticipo.

Contesto della proprietà: Kneafsey è classificato come Dirigente – Responsabile delle Entrate; non è indicato alcun ruolo di direttore né una partecipazione superiore al 10%. La comunicazione è stata effettuata da un unico soggetto notificante e non sono state riportate transazioni su strumenti derivati.

Considerazioni per gli investitori: Sebbene qualsiasi vendita da parte di un insider possa attirare attenzione, la dimensione di questa vendita è contenuta rispetto alla quota residua dell’insider e l’esecuzione nell’ambito di un piano 10b5-1 riduce i segnali potenzialmente negativi. Nel documento non sono fornite informazioni sulle performance operative di Blend Labs, sugli utili o su altri eventi societari.

Resumen del Formulario 4: Blend Labs, Inc. (BLND) presentó un Formulario 4 en el que se revela que Brian Kneafsey, Jefe de Ingresos de la compañía, vendió 20,000 acciones ordinarias Clase A el 23 de junio de 2025.

Detalles de la transacción: La disposición fue clasificada como “S” (venta en mercado abierto) y se ejecutó a un precio promedio ponderado de $3.1657 por acción, dentro de un rango de $3.12 a $3.205. Tras la venta, Kneafsey aún posee 806,598 acciones, lo que indica que la transacción redujo su participación directa en aproximadamente un 2.5%.

Plan Rule 10b5-1: El insider indicó que la operación se realizó bajo un plan de trading Rule 10b5-1 adoptado el 14 de marzo de 2025. Los planes preestablecidos pueden mitigar preocupaciones sobre ventajas informativas, ya que las operaciones se programan con anticipación.

Contexto de propiedad: Kneafsey está clasificado como Oficial – Jefe de Ingresos; no se indicó estatus de director ni de propietario del 10%. La presentación fue realizada por una sola persona informante y no se reportaron transacciones con valores derivados.

Conclusiones para inversores: Aunque cualquier venta de un insider puede llamar la atención, el tamaño de esta venta es modesto en relación con la participación restante del insider y su ejecución bajo un plan 10b5-1 disminuye las posibles señales negativas. No se proporciona información sobre el desempeño operativo, ganancias u otros eventos corporativos de Blend Labs en esta presentación.

Form 4 개요: Blend Labs, Inc.(BLND)는 2025년 6월 23일에 회사 매출 책임자인 Brian Kneafsey가 클래스 A 보통주 20,000주를 매도했다는 내용을 공개하는 Form 4를 제출했습니다.

거래 세부사항: 이번 매도는 “S”(시장 내 매도)로 분류되었으며, 주당 가중 평균 가격 $3.1657에, $3.12에서 $3.205 사이의 가격 범위 내에서 실행되었습니다. 매도 후 Kneafsey는 여전히 806,598주를 보유하고 있어 보유 지분이 약 2.5% 감소했음을 나타냅니다.

Rule 10b5-1 계획: 내부자는 이번 거래가 2025년 3월 14일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌다고 밝혔습니다. 사전 계획된 거래는 거래가 사전에 예약되어 있기 때문에 정보 우위에 대한 우려를 완화할 수 있습니다.

소유권 맥락: Kneafsey는 임원 – 매출 책임자로 분류되며, 이사나 10% 이상 소유자 지위는 표시되지 않았습니다. 제출은 단일 보고자가 했으며 파생 증권 거래는 보고되지 않았습니다.

투자자 시사점: 내부자 매도는 주목을 받을 수 있으나, 이번 매도 규모는 내부자의 남은 지분에 비해 적당하며, 10b5-1 계획에 따라 실행된 점이 부정적 신호 가능성을 줄입니다. 본 제출서에는 Blend Labs의 운영 실적, 수익 또는 기타 기업 이벤트에 관한 정보는 포함되어 있지 않습니다.

Vue d'ensemble du Formulaire 4 : Blend Labs, Inc. (BLND) a déposé un Formulaire 4 révélant que Brian Kneafsey, Directeur des Revenus de la société, a vendu 20 000 actions ordinaires de Classe A le 23 juin 2025.

Détails de la transaction : La cession a été codée « S » (vente sur le marché ouvert) et exécutée à un prix moyen pondéré de 3,1657 $ par action, dans une fourchette de 3,12 $ à 3,205 $. Après la vente, Kneafsey détient toujours 806 598 actions, ce qui indique que la transaction a réduit sa participation directe d'environ 2,5 %.

Plan Rule 10b5-1 : L'initié a précisé que la transaction a été réalisée dans le cadre d'un plan de trading Rule 10b5-1 adopté le 14 mars 2025. Les plans préétablis peuvent atténuer les préoccupations liées à un avantage d'information car les transactions sont programmées à l'avance.

Contexte de propriété : Kneafsey est classé comme Dirigeant – Directeur des Revenus ; aucun statut de directeur ou de détenteur de plus de 10 % n'a été indiqué. La déclaration est effectuée par une seule personne déclarante et aucune transaction sur titres dérivés n'a été signalée.

Points à retenir pour les investisseurs : Bien que toute vente d'initié puisse attirer l'attention, l'ampleur de cette vente est modeste par rapport à la participation restante de l'initié, et son exécution dans le cadre d'un plan 10b5-1 réduit les signaux potentiellement négatifs. Aucune information sur la performance opérationnelle, les bénéfices ou d'autres événements d'entreprise de Blend Labs n'est fournie dans ce dépôt.

Übersicht Formular 4: Blend Labs, Inc. (BLND) reichte ein Formular 4 ein, das offenlegt, dass Brian Kneafsey, Leiter des Umsatzbereichs, am 23. Juni 2025 20.000 Aktien der Klasse A des Unternehmens verkauft hat.

Transaktionsdetails: Die Veräußerung wurde als „S“ (Offenmarktverkauf) codiert und zu einem gewichteten Durchschnittspreis von 3,1657 $ pro Aktie ausgeführt, innerhalb einer Spanne von 3,12 bis 3,205 $. Nach dem Verkauf besitzt Kneafsey noch 806.598 Aktien, was darauf hinweist, dass seine direkten Bestände um etwa 2,5 % reduziert wurden.

Rule 10b5-1 Plan: Der Insider gab an, dass der Handel im Rahmen eines am 14. März 2025 eingeführten Rule 10b5-1 Handelsplans durchgeführt wurde. Vorgeplante Pläne können Bedenken hinsichtlich eines Informationsvorteils mindern, da die Trades im Voraus terminiert sind.

Eigentumskontext: Kneafsey wird als Offizier – Leiter Umsatz klassifiziert; es wurde kein Direktor- oder 10%-Eigentümerstatus angegeben. Die Meldung erfolgt durch eine einzelne berichtspflichtige Person, und es wurden keine Transaktionen mit Derivaten gemeldet.

Investoren-Fazit: Obwohl jeder Insider-Verkauf Aufmerksamkeit erregen kann, ist das Volumen dieses Verkaufs im Verhältnis zum verbleibenden Anteil des Insiders moderat, und die Ausführung im Rahmen eines 10b5-1 Plans verringert potenziell negative Signale. In dieser Meldung werden keine Informationen zur operativen Leistung, zu Gewinnen oder anderen Unternehmensereignissen von Blend Labs bereitgestellt.

Positive
  • Trade executed under a Rule 10b5-1 plan, reducing concerns about opportunistic selling.
  • Insider retains a substantial 806,598-share position, maintaining alignment with shareholders.
Negative
  • Officer disposed of 20,000 shares, a potential though modest negative signal.

Insights

TL;DR – Small, pre-planned insider sale; neutral market impact.

Insider sales often trigger caution, but this 20,000-share disposition equals only about 2.5% of Brian Kneafsey’s holdings. The transaction was executed under a Rule 10b5-1 plan, suggesting it was scheduled independently of near-term company news. No derivative positions changed, and the executive still owns more than 800k shares, maintaining meaningful alignment with shareholders. Given the limited size and pre-arranged nature, I view the filing as neutral for valuation or sentiment; it does not materially alter the investment thesis for BLND.

Panoramica del Modulo 4: Blend Labs, Inc. (BLND) ha presentato un Modulo 4 che rivela che Brian Kneafsey, Responsabile delle Entrate dell'azienda, ha venduto 20.000 azioni ordinarie di Classe A il 23 giugno 2025.

Dettagli della transazione: La cessione è stata classificata come “S” (vendita sul mercato aperto) ed è stata eseguita a un prezzo medio ponderato di 3,1657 $ per azione, in un intervallo compreso tra 3,12 e 3,205 $. Dopo la vendita, Kneafsey detiene ancora 806.598 azioni, il che indica che la transazione ha ridotto la sua partecipazione diretta di circa il 2,5%.

Piano Rule 10b5-1: L’insider ha specificato che la vendita è stata effettuata nell’ambito di un piano di trading Rule 10b5-1 adottato il 14 marzo 2025. I piani predefiniti possono ridurre le preoccupazioni relative a vantaggi informativi poiché le operazioni sono programmate in anticipo.

Contesto della proprietà: Kneafsey è classificato come Dirigente – Responsabile delle Entrate; non è indicato alcun ruolo di direttore né una partecipazione superiore al 10%. La comunicazione è stata effettuata da un unico soggetto notificante e non sono state riportate transazioni su strumenti derivati.

Considerazioni per gli investitori: Sebbene qualsiasi vendita da parte di un insider possa attirare attenzione, la dimensione di questa vendita è contenuta rispetto alla quota residua dell’insider e l’esecuzione nell’ambito di un piano 10b5-1 riduce i segnali potenzialmente negativi. Nel documento non sono fornite informazioni sulle performance operative di Blend Labs, sugli utili o su altri eventi societari.

Resumen del Formulario 4: Blend Labs, Inc. (BLND) presentó un Formulario 4 en el que se revela que Brian Kneafsey, Jefe de Ingresos de la compañía, vendió 20,000 acciones ordinarias Clase A el 23 de junio de 2025.

Detalles de la transacción: La disposición fue clasificada como “S” (venta en mercado abierto) y se ejecutó a un precio promedio ponderado de $3.1657 por acción, dentro de un rango de $3.12 a $3.205. Tras la venta, Kneafsey aún posee 806,598 acciones, lo que indica que la transacción redujo su participación directa en aproximadamente un 2.5%.

Plan Rule 10b5-1: El insider indicó que la operación se realizó bajo un plan de trading Rule 10b5-1 adoptado el 14 de marzo de 2025. Los planes preestablecidos pueden mitigar preocupaciones sobre ventajas informativas, ya que las operaciones se programan con anticipación.

Contexto de propiedad: Kneafsey está clasificado como Oficial – Jefe de Ingresos; no se indicó estatus de director ni de propietario del 10%. La presentación fue realizada por una sola persona informante y no se reportaron transacciones con valores derivados.

Conclusiones para inversores: Aunque cualquier venta de un insider puede llamar la atención, el tamaño de esta venta es modesto en relación con la participación restante del insider y su ejecución bajo un plan 10b5-1 disminuye las posibles señales negativas. No se proporciona información sobre el desempeño operativo, ganancias u otros eventos corporativos de Blend Labs en esta presentación.

Form 4 개요: Blend Labs, Inc.(BLND)는 2025년 6월 23일에 회사 매출 책임자인 Brian Kneafsey가 클래스 A 보통주 20,000주를 매도했다는 내용을 공개하는 Form 4를 제출했습니다.

거래 세부사항: 이번 매도는 “S”(시장 내 매도)로 분류되었으며, 주당 가중 평균 가격 $3.1657에, $3.12에서 $3.205 사이의 가격 범위 내에서 실행되었습니다. 매도 후 Kneafsey는 여전히 806,598주를 보유하고 있어 보유 지분이 약 2.5% 감소했음을 나타냅니다.

Rule 10b5-1 계획: 내부자는 이번 거래가 2025년 3월 14일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌다고 밝혔습니다. 사전 계획된 거래는 거래가 사전에 예약되어 있기 때문에 정보 우위에 대한 우려를 완화할 수 있습니다.

소유권 맥락: Kneafsey는 임원 – 매출 책임자로 분류되며, 이사나 10% 이상 소유자 지위는 표시되지 않았습니다. 제출은 단일 보고자가 했으며 파생 증권 거래는 보고되지 않았습니다.

투자자 시사점: 내부자 매도는 주목을 받을 수 있으나, 이번 매도 규모는 내부자의 남은 지분에 비해 적당하며, 10b5-1 계획에 따라 실행된 점이 부정적 신호 가능성을 줄입니다. 본 제출서에는 Blend Labs의 운영 실적, 수익 또는 기타 기업 이벤트에 관한 정보는 포함되어 있지 않습니다.

Vue d'ensemble du Formulaire 4 : Blend Labs, Inc. (BLND) a déposé un Formulaire 4 révélant que Brian Kneafsey, Directeur des Revenus de la société, a vendu 20 000 actions ordinaires de Classe A le 23 juin 2025.

Détails de la transaction : La cession a été codée « S » (vente sur le marché ouvert) et exécutée à un prix moyen pondéré de 3,1657 $ par action, dans une fourchette de 3,12 $ à 3,205 $. Après la vente, Kneafsey détient toujours 806 598 actions, ce qui indique que la transaction a réduit sa participation directe d'environ 2,5 %.

Plan Rule 10b5-1 : L'initié a précisé que la transaction a été réalisée dans le cadre d'un plan de trading Rule 10b5-1 adopté le 14 mars 2025. Les plans préétablis peuvent atténuer les préoccupations liées à un avantage d'information car les transactions sont programmées à l'avance.

Contexte de propriété : Kneafsey est classé comme Dirigeant – Directeur des Revenus ; aucun statut de directeur ou de détenteur de plus de 10 % n'a été indiqué. La déclaration est effectuée par une seule personne déclarante et aucune transaction sur titres dérivés n'a été signalée.

Points à retenir pour les investisseurs : Bien que toute vente d'initié puisse attirer l'attention, l'ampleur de cette vente est modeste par rapport à la participation restante de l'initié, et son exécution dans le cadre d'un plan 10b5-1 réduit les signaux potentiellement négatifs. Aucune information sur la performance opérationnelle, les bénéfices ou d'autres événements d'entreprise de Blend Labs n'est fournie dans ce dépôt.

Übersicht Formular 4: Blend Labs, Inc. (BLND) reichte ein Formular 4 ein, das offenlegt, dass Brian Kneafsey, Leiter des Umsatzbereichs, am 23. Juni 2025 20.000 Aktien der Klasse A des Unternehmens verkauft hat.

Transaktionsdetails: Die Veräußerung wurde als „S“ (Offenmarktverkauf) codiert und zu einem gewichteten Durchschnittspreis von 3,1657 $ pro Aktie ausgeführt, innerhalb einer Spanne von 3,12 bis 3,205 $. Nach dem Verkauf besitzt Kneafsey noch 806.598 Aktien, was darauf hinweist, dass seine direkten Bestände um etwa 2,5 % reduziert wurden.

Rule 10b5-1 Plan: Der Insider gab an, dass der Handel im Rahmen eines am 14. März 2025 eingeführten Rule 10b5-1 Handelsplans durchgeführt wurde. Vorgeplante Pläne können Bedenken hinsichtlich eines Informationsvorteils mindern, da die Trades im Voraus terminiert sind.

Eigentumskontext: Kneafsey wird als Offizier – Leiter Umsatz klassifiziert; es wurde kein Direktor- oder 10%-Eigentümerstatus angegeben. Die Meldung erfolgt durch eine einzelne berichtspflichtige Person, und es wurden keine Transaktionen mit Derivaten gemeldet.

Investoren-Fazit: Obwohl jeder Insider-Verkauf Aufmerksamkeit erregen kann, ist das Volumen dieses Verkaufs im Verhältnis zum verbleibenden Anteil des Insiders moderat, und die Ausführung im Rahmen eines 10b5-1 Plans verringert potenziell negative Signale. In dieser Meldung werden keine Informationen zur operativen Leistung, zu Gewinnen oder anderen Unternehmensereignissen von Blend Labs bereitgestellt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kneafsey Brian

(Last) (First) (Middle)
7250 REDWOOD BLVD., SUITE 300

(Street)
NOVATO CA 94945

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Blend Labs, Inc. [ BLND ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Head of Revenue
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 06/23/2025 S(1) 20,000 D $3.1657(2) 806,598 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.
2. This sale price represents the weighted average sale price of the shares sold ranging from $3.12 to $3.205, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
/s/ Winnie Ling, Attorney-in-fact 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Blend Labs (BLND) shares did Brian Kneafsey sell?

He sold 20,000 Class A common shares.

At what average price were the BLND shares sold?

The weighted-average sale price was $3.1657, within a $3.12–$3.205 range.

What is Brian Kneafsey’s remaining BLND share ownership after the sale?

He now beneficially owns 806,598 shares.

Was the transaction conducted under a 10b5-1 trading plan?

Yes. The filing states it was effected under a Rule 10b5-1 plan adopted on 14 Mar 2025.

What is Brian Kneafsey’s role at Blend Labs?

He is listed as an Officer – Head of Revenue.
Blend Labs Inc

NYSE:BLND

BLND Rankings

BLND Latest News

BLND Latest SEC Filings

BLND Stock Data

850.54M
244.01M
4.31%
67.56%
3.35%
Software - Application
Services-computer Programming, Data Processing, Etc.
Link
United States
NOVATO